Prognostic value of sarcopenia in aortic valve replacement: a systematic review and meta-analysis

ObjectiveThis study aimed to quantify the prevalence of sarcopenia in patients undergoing surgical aortic valve replacement (SAVR) or transcatheter aortic valve replacement (TAVR), and to assess its association with mortality risk.MethodsRelevant studies were identified through searches of the PubMe...

Full description

Saved in:
Bibliographic Details
Main Author: Jie He
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-07-01
Series:Frontiers in Nutrition
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnut.2025.1529270/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849245950586912768
author Jie He
Jie He
author_facet Jie He
Jie He
author_sort Jie He
collection DOAJ
description ObjectiveThis study aimed to quantify the prevalence of sarcopenia in patients undergoing surgical aortic valve replacement (SAVR) or transcatheter aortic valve replacement (TAVR), and to assess its association with mortality risk.MethodsRelevant studies were identified through searches of the PubMed, Cochrane Library, Excerpta Medica Database (Embase), Web of Science, and China National Knowledge Infrastructure (CNKI) from inception through July 1, 2025. The prevalence of sarcopenia and its 95% confidence interval (CI) were calculated, with heterogeneity evaluated using the I2 statistic. The link between sarcopenia and mortality following SAVR/TAVR was quantified by hazard ratio (HR) or odds ratio (OR) with 95% CI. Statistical analyses were conducted using Stata 11.0.ResultsThirty-eight studies were included, with 6 focusing on patients undergoing SAVR and 32 on those undergoing TAVR. Sarcopenia was defined by skeletal mass index in 16 studies, while only 2 studies adopted criteria combining reduced muscle mass with low muscle strength and/or reduced physical performance. Sarcopenia’s prevalence among SAVR patients was 31.3% (95% CI 25.3–37.6%). In this cohort, sarcopenia was linked to a significantly higher risk of long-term (≥1 year) mortality (HR = 3.10, 95% CI 2.00–4.79, p < 0.001). In contrast, the prevalence of sarcopenia in TAVR patients was 43.7% (95% CI 38.6–48.9%), with sarcopenia also correlating with increased long-term (>2 year) mortality (HR = 1.25, 95% CI 1.09–1.44, p = 0.001). These associations remained consistent across various follow-up durations, definitions of sarcopenia, and ethnic groups.ConclusionDespite the variation in diagnostic criteria, sarcopenia is significantly prevalent in both SAVR and TAVR populations, with a clear association with elevated long-term mortality following these procedures.Systematic review registrationhttps://www.crd.york.ac.uk/PROSPERO/, identifier CRD42024606633.
format Article
id doaj-art-4b3b0c2300b54fc5b504d0edf11d9f10
institution Kabale University
issn 2296-861X
language English
publishDate 2025-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Nutrition
spelling doaj-art-4b3b0c2300b54fc5b504d0edf11d9f102025-08-20T03:58:40ZengFrontiers Media S.A.Frontiers in Nutrition2296-861X2025-07-011210.3389/fnut.2025.15292701529270Prognostic value of sarcopenia in aortic valve replacement: a systematic review and meta-analysisJie He0Jie He1School of Clinical Medicine, Chengdu Medical College, Chengdu, Sichuan, ChinaDepartment of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan, ChinaObjectiveThis study aimed to quantify the prevalence of sarcopenia in patients undergoing surgical aortic valve replacement (SAVR) or transcatheter aortic valve replacement (TAVR), and to assess its association with mortality risk.MethodsRelevant studies were identified through searches of the PubMed, Cochrane Library, Excerpta Medica Database (Embase), Web of Science, and China National Knowledge Infrastructure (CNKI) from inception through July 1, 2025. The prevalence of sarcopenia and its 95% confidence interval (CI) were calculated, with heterogeneity evaluated using the I2 statistic. The link between sarcopenia and mortality following SAVR/TAVR was quantified by hazard ratio (HR) or odds ratio (OR) with 95% CI. Statistical analyses were conducted using Stata 11.0.ResultsThirty-eight studies were included, with 6 focusing on patients undergoing SAVR and 32 on those undergoing TAVR. Sarcopenia was defined by skeletal mass index in 16 studies, while only 2 studies adopted criteria combining reduced muscle mass with low muscle strength and/or reduced physical performance. Sarcopenia’s prevalence among SAVR patients was 31.3% (95% CI 25.3–37.6%). In this cohort, sarcopenia was linked to a significantly higher risk of long-term (≥1 year) mortality (HR = 3.10, 95% CI 2.00–4.79, p < 0.001). In contrast, the prevalence of sarcopenia in TAVR patients was 43.7% (95% CI 38.6–48.9%), with sarcopenia also correlating with increased long-term (>2 year) mortality (HR = 1.25, 95% CI 1.09–1.44, p = 0.001). These associations remained consistent across various follow-up durations, definitions of sarcopenia, and ethnic groups.ConclusionDespite the variation in diagnostic criteria, sarcopenia is significantly prevalent in both SAVR and TAVR populations, with a clear association with elevated long-term mortality following these procedures.Systematic review registrationhttps://www.crd.york.ac.uk/PROSPERO/, identifier CRD42024606633.https://www.frontiersin.org/articles/10.3389/fnut.2025.1529270/fullSAVRTAVRsarcopeniaprevalencesystematic reviewmeta-analysis
spellingShingle Jie He
Jie He
Prognostic value of sarcopenia in aortic valve replacement: a systematic review and meta-analysis
Frontiers in Nutrition
SAVR
TAVR
sarcopenia
prevalence
systematic review
meta-analysis
title Prognostic value of sarcopenia in aortic valve replacement: a systematic review and meta-analysis
title_full Prognostic value of sarcopenia in aortic valve replacement: a systematic review and meta-analysis
title_fullStr Prognostic value of sarcopenia in aortic valve replacement: a systematic review and meta-analysis
title_full_unstemmed Prognostic value of sarcopenia in aortic valve replacement: a systematic review and meta-analysis
title_short Prognostic value of sarcopenia in aortic valve replacement: a systematic review and meta-analysis
title_sort prognostic value of sarcopenia in aortic valve replacement a systematic review and meta analysis
topic SAVR
TAVR
sarcopenia
prevalence
systematic review
meta-analysis
url https://www.frontiersin.org/articles/10.3389/fnut.2025.1529270/full
work_keys_str_mv AT jiehe prognosticvalueofsarcopeniainaorticvalvereplacementasystematicreviewandmetaanalysis
AT jiehe prognosticvalueofsarcopeniainaorticvalvereplacementasystematicreviewandmetaanalysis